SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-18-000515
Filing Date
2018-10-31
Accepted
2018-10-31 12:44:51
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTNEA 13 GP, LTDNEA PARTNERS 13, L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOC. 13, LP - PHASEBIO PHARMACEUTICALS, INC. -- SCHEDULE 13D phasebio13d_18260.htm SC 13D 317176
  Complete submission text file 0001072613-18-000515.txt   319091
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90691 | Film No.: 181149461
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D